A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women
Open accessAbstract
Background Low intake of dietary fat and high intake of soy foods have been suggested to partly explain the lower breast cancer rates in Asia, perhaps because of lower endogenous estrogens. Objective The objective was to assess the hormonal and nonhormonal effects of diets resembling an Asian diet in terms of total fat and soy food contents. Design Fifty-seven postmenopausal women participated in a randomized, controlled, dietary intervention study. The subjects consumed a very-low-fat diet (VLFD; 11% of energy as fat), a Step I diet (25% of energy as fat) supplemented with soy food (SFD; 50 mg isoflavones/d), or a control Step I diet (CD; 27% of energy as fat) with no soy food. All diets were prepared at the General Clinical Research Center of the University of Southern California. Serum hormones and other markers were measured at baseline and every 2 wk during the 8 wk of intervention. Results There were no significant differences in total estradiol and sex hormone binding globulin at the completion of the intervention between women in the SFD and VLFD groups and those in the CD group. Serum insulin decreased significantly in the SFD group, and leptin decreased significantly in the SFD and VLFD groups; however, these changes did not differ significantly from the changes in the CD group. Conclusions This study does not provide evidence that ingestion of soy food or a VLFD significantly reduces estrogen concentrations in postmenopausal women. However, short-term changes in di…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A total of 18 RCTs assessed circulating estrogen levels; 15 of 18 found no significant impact from soy compared to control.
“A total of 18 RCTs assessed circulating estrogens levels (E1, E2, and/ or E3) Fifteen of 18 studies found no significant impact from soy compared to the control group (p>0.05) [129,132,133,138,140,143,145,147,149,150,155,156,158,160,163].”
From Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review (2013) · cites this paper as [140]
Cites
Yu-Poth, S., Zhao, G., Etherton, T., Naglak, M., Jonnalagadda, S., & Kris-Etherton, P. M. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.4.632 · Cited by 584 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Epidemiology of soy exposures and breast cancer risk
Wu, A. H., Yu, M. C., Tseng, C.-C., & Pike, M. C. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604145 · Cited by 418 · see citing works
Self-citationSoy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review
Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081968 · Cited by 188 · see citing works
Inflammatory markers in a 2-year soy intervention among premenopausal women
Maskarinec, G., Sofias, J. S., Franke, A. A., & Cooney, R. V. (2009) · Journal of Inflammation · doi:10.1186/1476-9255-6-9 · Cited by 34 · see citing works
- Authors
- Wu, A. H., Stanczyk, F. Z., Martinez, C., Tseng, C.-C., Hendrich, S., Murphy, P., Chaikittisilpa, S., Stram, D. O., & Pike, M. C.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Wu, Anna H
- ORCID
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 81
- Issue
- 5
- Pages
- 1133-1141
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2131457976
- Cited by
- 47
- References
- 1
- Citations by year
- 2022: 2 · 2021: 2 · 2020: 3 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 2.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (2P30 CA14089-26, P30CA014089)
- National Institute of Environmental Health Sciences (P30ES007048)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- dietary fat reduction, postmenopausal women, very low-fat diet, isoflavones, estradiol, sex hormone-binding globulin, insulin, leptin, Asian diet, breast cancer risk, endogenous estrogen
- MeSH terms
- Dietary Fats, Estrogens, Female, Food Analysis, Humans, Insulin, Isoflavones, Middle Aged, Postmenopause, Leptin, Soybean Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review